Cargando…

Regression of Lung Cancer in Mice by Intranasal Administration of SARS-CoV-2 Spike S1

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer related deaths worldwide, with a relatively low 5-year survival rate. Although there are many therapies against lung cancer, significant improvements in overall survival have not been reported. Therefore, new effective treatment options are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheinin, Monica, Jeong, Brian, Paidi, Ramesh K., Pahan, Kalipada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688283/ https://www.ncbi.nlm.nih.gov/pubmed/36428739 http://dx.doi.org/10.3390/cancers14225648

Ejemplares similares

Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses
por: Paidi, Ramesh Kumar, et al.
Publicado: (2021)

ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy
por: Paidi, Ramesh K., et al.
Publicado: (2021)

Muscle-building supplement β-hydroxy β-methylbutyrate binds to PPARα to improve hippocampal functions in mice
por: Paidi, Ramesh K., et al.
Publicado: (2023)

Treadmill exercise reduces α-synuclein spreading via PPARα
por: Dutta, Debashis, et al.
Publicado: (2022)

Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models
por: Dutta, Debashis, et al.
Publicado: (2023)

Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy
por: Mondal, Susanta, et al.
Publicado: (2015)

Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models
por: Freitag, Tobias L., et al.
Publicado: (2023)

Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer
por: Kundu, Madhuchhanda, et al.
Publicado: (2022)

Can cinnamon bring aroma in Parkinson's disease treatment?
por: Pahan, Priyanka, et al.
Publicado: (2015)

Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
por: Pahan, Priyanka, et al.
Publicado: (2020)

Prospects of Cinnamon in Multiple Sclerosis
por: Pahan, Kalipada
Publicado: (2015)

Protection of Mice from Controlled Cortical Impact Injury by Food Additive Glyceryl Tribenzoate
por: Rangasamy, Suresh B., et al.
Publicado: (2023)

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
por: Halwe, Sandro, et al.
Publicado: (2021)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
por: Stark, Felicity C., et al.
Publicado: (2022)

Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis
por: Roy, Avik, et al.
Publicado: (2013)

Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease via Peroxisome Proliferator-Activated Receptor α
por: Chandra, Sujyoti, et al.
Publicado: (2019)

Is COVID-19 Gender-sensitive?
por: Mukherjee, Shreya, et al.
Publicado: (2021)

Cinnamein Inhibits the Induction of Nitric Oxide and Proinflammatory Cytokines in Macrophages, Microglia and Astrocytes
por: Pahan, Swarupa, et al.
Publicado: (2023)

Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters
por: Wouters, Elise, et al.
Publicado: (2023)

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection
por: Supramaniam, Aroon, et al.
Publicado: (2023)

Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Improves Cognitive Functions in Mice after Controlled Cortical Impact Injury
por: Rangasamy, Suresh B., et al.
Publicado: (2021)

Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
por: Park, Hong-Su, et al.
Publicado: (2022)

The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2022)

Intranasal administration of resveratrol successfully prevents lung cancer in A/J mice
por: Monteillier, Aymeric, et al.
Publicado: (2018)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
por: Hassan, Ahmed O., et al.
Publicado: (2021)

Upregulation of Myelin Gene Expression by a Physically-Modified Saline via Phosphatidylinositol 3-Kinase-Mediated Activation of CREB: Implications for Multiple Sclerosis
por: Jana, Malabendu, et al.
Publicado: (2017)

Glyceryl Tribenzoate: A Flavoring Ingredient, Inhibits the Adoptive Transfer of Experimental Allergic Encephalomyelitis via TGF-β: Implications for Multiple Sclerosis Therapy
por: Mondal, Susanta, et al.
Publicado: (2017)

A simple protocol for isolating microglia from adult mouse brain
por: Chakrabarti, Sudipta, et al.
Publicado: (2023)

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
por: Abdoli, Mohsen, et al.
Publicado: (2022)

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
por: Wu, Xilin, et al.
Publicado: (2021)

Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish
por: Kraus, Aurora, et al.
Publicado: (2022)

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both
por: Beitari, Saina, et al.
Publicado: (2023)

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021)

Anxiolytic Action of Taurine via Intranasal Administration in Mice
por: Jung, Jung Hwa, et al.
Publicado: (2019)

HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration
por: Lu, Ying, et al.
Publicado: (2023)

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice
por: Qu, Di, et al.
Publicado: (2005)

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
por: Sengupta, Anirban, et al.
Publicado: (2022)

Reducing transmission of SARS-CoV-2 with intranasal prophylaxis
por: Boiardi, Federico, et al.
Publicado: (2020)

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
por: Adashi, Eli Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u56ojh9amp8l7nrlgj1jt4otc6